###### Strengths and limitations of this study

-   To the best of our knowledge, performing this review will result in the first article giving an overview of the existing evidence of biomechanical factors that are associated with the development of knee osteoarthritis (KOA).

-   This review does not assess the mechanism of how the biomechanical factors are related to the development of KOA.

-   This is a protocol article. Results of the systematic review and meta-analysis will be published in a different article.

Introduction {#s1}
============

The aetiology of osteoarthritis is known to be both biological and mechanical.[@R1] Although the sequence is unknown, increased joint loading and altered biomechanics might lead to tissue damage. This might deteriorate into structural changes, potentially with symptoms of osteoarthritis such as pain and activity limitations. In turn, structural changes might lead to further altered biomechanics, forming a vicious cycle.

A recent systematic review showed that several other risk factors, such as age, gender, body mass index (BMI) and previous knee injury, were associated with the development of knee pain or knee osteoarthritis (KOA), in those aged 50 years and over.[@R2] In an editorial accompanying this review, Zhang[@R3] suggested that a systematic review and meta-analysis in biomechanical risk factors should also be performed. We have defined biomechanical factors as joint-related factors that interact with the forces, moments and kinematics in and around the knee joint. Current research into biomechanical factors focuses on four main biomechanical impairments relevant to tibiofemoral KOA, that is, skeletal malalignment, impaired proprioception, muscle dysfunction and laxity ([table 1](#BMJOPEN2016011066TB1){ref-type="table"}). Skeletal malalignment refers to abnormal alignment of or deformity within the knee joint. Valgus and varus malalignment might lead to increased loads in the lateral and medial compartment of the tibiofemoral joint, respectively, and thus a possible increased risk for the development of KOA. Impaired proprioception refers to a deterioration of the senses of knee joint position and movement, or a primary neurological defect. This might lead to more excessive movements, decreased stabilisation during stance and decreased coordination of complex movement systems and precise knee joint motions. Deterioration of those three functions of knee proprioception might lead to increased joint loading and structural changes.[@R4] Muscle dysfunction refers to a loss of muscle strength, or muscle weakness, to loss of muscle endurance, and to changed muscle activation patterns for the muscles that act on the knee joint. It is suggested that the knee extensors protect the joint during loading and movement, by absorbing shocks and stabilising the knee.[@R5] On the contrary, higher strength could also lead to higher loads in the knee joint because of joint space narrowing induced by muscle strength. Laxity refers to a loss of passive joint stabilisation due to the inability of passive structures in and around the knee (knee ligaments, cruciate ligaments and capsule) to provide an adequate counterbalance to the mechanical forces acting on the knee during activity. For example, lateral laxity allows the lateral femoral condyle to 'lift of' the tibial plateau, which increases the medial joint loading.[@R6] Laxity may adversely affect other biomechanical factors.[@R7] Alteration in these four biomechanical impairments will impact on the loading of the knee. Abnormal loading is associated with imbalances that may eventually lead to KOA.[@R8] Within the development of KOA, biomechanical factors and other risk factors will interact with each other. For example, gender is associated with malalignment, and previous knee injury has been shown to increase laxity. Although it is not possible to reduce the risk to develop KOA based on other risk factors, it might be possible to reduce the additional risk of the biomechanical factors by preventive strategies (eg, knee braces, insoles or physical therapy).

###### 

Biomechanical impairments and risk factors relevant to the development of KOA, subdivision, and measurement

                     Impairment/risk factor    Subdivision            Measurement
  ------------------ ------------------------- ---------------------- ---------------------------------------------------------------
  Abnormal loading                                                    Moments, KRF, KCF, thrust
                     Skeletal malalignment                            Leg alignment (eg, HKA), Q-angle
                     Muscular dysfunction      Muscular               Strength, HQ-ratio
                                               Neurological           Activation pattern, RFD, cocontraction, coactivation
                     Impaired proprioception   Joint position sense   Error, accuracy
                                               Joint movement sense   Threshold
                     Laxity                    Anterior-posterior     Joint line opening with stress
                                               Varus--valgus          Joint line opening with stress
                     High BMI                  Categorical\*          Eg, obese, BMI\>30
                                               Continuous             BMI
                     Gender                    Categorical\*          Male, female
                     Previous knee injury†     Categorical\*          Eg, ligament rupture, meniscal lesion, tibia plateau fracture
                     Age                       Categorical\*          Eg, middle-aged, elderly
                                               Continuous             Age

\*Comparable categorical risk factors will be grouped in analyses, based on decision by the two reviewers.

†Studies should not be influenced by rehabilitation or surgical treatment.

BMI, body mass index; HKA, hip-knee-ankle-angle; H/Q ratio, Hamstrings/Quadriceps ratio; KCF, knee contact force; KOA, knee osteoarthritis; KRF, knee reaction force; RFD, rate of force development.

The relationship between biomechanical factors and the development of KOA has been indicated in several biomechanical studies and systematic reviews, but there is no systematic review available that contains an overview of all available evidence of the influence of particularly biomechanical factors on the development of KOA.[@R5] [@R9] Although each biomechancial factor will be assessed with several different methods, and most studies most probably have a cross-sectional study design, we expect to be able to give an overview of biomechancial factors that are associated with (the development of) KOA. Such an overview may be used to identify persons at high risk of developing KOA. Several strategies like physical therapy, knee braces or insoles might prevent the development of KOA in those persons by interacting on the biomechanical factors. In addition, an overview provides information that can be used to base the rationale behind strategies to prevent the development of KOA on and to identify the focus of future biomechanical and clinical studies.

Objectives {#s1a}
----------

The aim of this review is (1) to identify biomechanical factors that are associated with (the development of) KOA and (2) to identify the impact of other relevant risk factors on this association. Therefore, the proposed systematic review will answer the following questions: Which are the biomechanical factors that are associated with (the development of) KOA?Is the association of these biomechanical factors with (the development of) KOA mediated by other risk factors for KOA (ie, high BMI, female gender, history of previous knee injury and higher age)?

Methods and analysis {#s2}
====================

This review protocol is registered with the International Prospective Register of Systematic Reviews at the National Institute for Health Research and Center for Reviews and Dissemination (CRD) at the University of York (registration number: CRD42015025092).[@R12] This systematic review is reported following the Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocols guidance.[@R13] The systematic review will be reported following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidance.[@R14]

Studies will be selected according to the criteria outlined below.

Type of studies {#s2a}
---------------

Studies will be eligible if they are cohort, cross-sectional or case--control studies. The cohort studies can either be prospective or retrospective. All cohort studies should have a follow-up period of at least 1 year. Studies should not be influenced by rehabilitation or surgical treatment.

Type of participants {#s2b}
--------------------

Included studies will be cohort studies examining participants who do not have KOA at baseline but who have KOA at the follow-up measurement, and participants who do not have KOA at both baseline and follow-up. Those two groups will be referred to as 'developing KOA' and 'not developing KOA'. Other included studies will be case--control and cross-sectional studies that include both participants with KOA and healthy controls. Participants have KOA if one of the criteria described in [table 2](#BMJOPEN2016011066TB2){ref-type="table"}, or an outcome measure related to the criteria, is fulfilled. Both idiopathic and secondary KOA are eligible. Participants can have osteoarthritis in one or both knees, although data should be analysed for only one knee, in order to examine independent associations with KOA. Studies examining participants with both osteoarthritis of the hip and the knee will only be included if separate data of participants with KOA is available. Studies examining participants already having KOA at baseline (cohort studies) or studies examining 'healthy' controls having KOA in either the index or the contralateral knee (cross-sectional or case--control studies) according to aforementioned criteria will be excluded. Studies examining participants with osteoarthritis in the patellofemoral joint only will be excluded. Data regarding patellofemoral osteoarthritis will not be used, and we will exclude data of individuals stated to have a combination of patellofemoral and tibiofemoral osteoarthritis. Cohort studies examining incidence of KOA in other populations (eg, rheumatoid arthritis and hypermobility) will be included, although only data regarding KOA will be used.

###### 

Criteria of osteoarthritis, and hierarchy of definitions (ranking: A (high)---J (low))

  --- --------------------- ----------------------------------------------------------------------------------------------------------------
  A   Clinical KOA          According to clinical ACR criteria
  B   Radiological KOA      Kellgren and Lawrence grade≥2, or grade≥2/osteophytes, or Ahlback grade≥1
  C   Radiological KOA      OARSI atlas criteria: sum of osteophytes or JSN≥grade 2, or grade 1 JSN in combination with grade 1 osteophyte
  D   Clinical KOA          Knee pain and≥50 years
  E   Radiological KOA      Radiographic signs\*; only if the authors report the participants to have KOA
  F   Surgery due to KOA†   Arthroscopy used to describe KOA
  G   Surgery due to KOA†   Osteotomy due to KOA
  H   Surgery due to KOA†   Total knee replacement due to KOA
  I   KOA defined by MRI    KOA signs on MRI; only if the authors report the participants to have KOA
  J   Clinical KOA          Participants report to have KOA diagnosed by physician
  --- --------------------- ----------------------------------------------------------------------------------------------------------------

\*Eg, osteophytes, cartilage damage, joint space narrowing, bone marrow oedema.

†Only as outcome measure of cohort study.

ACR, American College of Rheumatology; JSN, joint space narrowing; KOA, knee osteoarthritis; OARSI, Osteoarthritis Research Society International.

Type of biomechanical factors {#s2c}
-----------------------------

Studies exploring the association of a biomechanical factor with (the development of) KOA will be reviewed. The biomechanical factors will be grouped into one group referring to abnormal loading, and four main biomechanical impairments relevant to KOA (see [table 1](#BMJOPEN2016011066TB1){ref-type="table"}). [Table 1](#BMJOPEN2016011066TB1){ref-type="table"} also describes frequently used ways to measure biomechanical factors. The possible inclusion of measurements of biomechanical factors not listed in [table 1](#BMJOPEN2016011066TB1){ref-type="table"} will be discussed by the reviewers (JT and ADI). Only biomechanical factors directly related to the knee joint will be taken into account. Joint angles during activities will be excluded due to limited reliability of these measurements. Measurements of moments, knee reaction forces and knee contact forces will be included as measurements of abnormal loading, in contrast with measurements of ground reaction forces and centre of pressure, because only the first gives a comprehensive estimate of the loading of the knee. The influence of other risk factors on the association of biomechanical factors with (the development of) KOA will also be reviewed. Studies that only explore non-biomechanical risk factors will be excluded from this review.

Types of outcome measure {#s2d}
------------------------

KOA in included studies can be defined by clinical, radiological, MRI or surgical criteria (see [table 2](#BMJOPEN2016011066TB2){ref-type="table"}).

Publication year and language {#s2e}
-----------------------------

There will be no restriction on publication year and language.

Sources and search strategy {#s2f}
---------------------------

The following databases will be searched from their inception until August 2015: MEDLINE via Pubmed, EMBASE via OVID, CINAHL (including preCINAHL) via EBSCO and SPORTDiscus via EBSCO. Reference lists from included studies and identified relevant reviews, textbooks and clinical guidelines will be searched for relevant references. A citation search will be performed on highly relevant studies. Experts in the field will be asked for relevant references to ensure literature saturation.

Literature search strategies will be developed using medical subject headings (MeSH) and text words related to osteoarthritis, biomechanical factors and study types. Search terms from other relevant reviews will be identified and will be complemented with additional terms for biomechanical factors. The MEDLINE search strategy is included in online [supplementary appendix](#SM1){ref-type="supplementary-material"} 1, and will be adjusted in order to apply it to other databases.

10.1136/bmjopen-2016-011066.supp1

Study inclusion and exclusion criteria {#s2g}
--------------------------------------

The inclusion criteria will be: The study assesses the association of a biomechanical factor with the development of KOA, and possibly the impact of other risk factors on this association.KOA is defined as tibiofemoral osteoarthritis, either idiopathic or secondary.A biomechanical factor is a knee joint-related factor that interacts with the forces, moments and kinematics in and around the knee joint.The study is a cohort study: Participants who do not have KOA at baseline but who have KOA at the follow-up measurement, and participants who do not have KOA at both baseline and follow-up.

or The study is a case--control study or a cross-sectional study: Participants with and without KOA.

The exclusion criteria will be: The study includes only participants with patellofemoral osteoarthritis.The study does not distinguish between hip osteoarthritis and KOA.The study is influenced by rehabilitation or surgical treatment.

Data management {#s2h}
---------------

References from all searches will be uploaded into EndNote (X7) bibliographic software (Thompson Reuters, Philadelphia, Pennsylvania, USA). Duplicates will be removed with the Systematic Review Assistant-Deduplication Module.[@R15] The remaining duplicates will be removed with EndNote duplicate removal, and manually by screening for duplicates, while the list of references will be sorted alphabetically based on author. All full text files will be stored in EndNote. For all studies reviewed in full text, a form regarding eligibility criteria check will be stored. Data from included studies will be entered into a data extraction form in Microsoft Excel. If a meta-analysis is eligible, the data will be transferred to STATA software (V13.0 or later, StataCorp LP) to do statistical analysis.

Selection process {#s2i}
-----------------

Two members of the study team (JT and ADI) will independently screen titles and abstracts of the studies obtained by the search strategy. The full text of any study will be obtained if it was judged eligible by at least one of the reviewers. Then, the two reviewers will use a standardised form to select studies eligible for inclusion in the review. Consensus on inclusion will be reached by discussion. Reasons for excluding studies based on the full text will be recorded. When more than one study is based on the same population and contains the same information with respect to the association at issue, only one study will be included. This will be based on the following order: (1) the publication with the largest sample size, (2) the most recent publication or (3) the study that examined KOA using the highest ranked outcome measure. Hierarchy of the definitions is described later at 'Data items, outcomes and hierarchy', and in [table 2](#BMJOPEN2016011066TB2){ref-type="table"}. If studies of the same study population present different information with respect to the association at issue, both studies will be included. A PRISMA flowchart will be completed to summarise the process. Neither of the review authors will be blinded to the journal titles, the study authors or the institutions.[@R16]

Data collection process {#s2j}
-----------------------

Two reviewers (JT and ADI) will independently extract data from the included studies using a customised form, piloted prior to use. Consensus on extracted data will be reached by discussion, and conflictive data extraction will be discussed with a third member of the study team (CJ or HL).

Data items, outcomes and hierarchy {#s2k}
----------------------------------

Data items that will be extracted from included studies are described in [table 3](#BMJOPEN2016011066TB3){ref-type="table"}. [Table 3](#BMJOPEN2016011066TB2){ref-type="table"} shows that in cohort studies, preferably the number of participants developing KOA and not developing KOA, and the number of participants exposed and not exposed to the biomechanical factor will be extracted. In cross-sectional or case--control studies, preferably the number of participants with and without KOA, and the number of participants exposed and not exposed to the biomechanical factor will be extracted. If this is not available, mean values for the biomechanical factors or ORs will be extracted, respectively. The same data extraction and analyses will be performed for biomechanical factors and other risk factors. Therefore, in the following paragraphs only biomechanical factors will be mentioned. The hierarchy for definitions of KOA is based on comprehensiveness of the definition and the use in clinical practise (see [table 2](#BMJOPEN2016011066TB2){ref-type="table"}, ranking: A--J). Symptomatic KOA is based on the American College of Rheumatology criteria.[@R17] Radiographic KOA is based on radiological atlases (eg, the Kellgren and Lawrence (K/L) Classification).[@R18] [@R19] In addition, physicians or authors can state that participants have KOA. The hierarchy will be used for study selection if more than one study examines the same population, and for data extraction in studies using two or more outcome measures of KOA. For the latter, only data regarding the highest ranked outcome measure will be extracted.

###### 

Data extraction

  All studies                                                                
  -------------------------------------------------------------------------- --------------------------------------------------------------
  First author                                                               Age (mean±SD)
  Year of publication                                                        BMI (mean±SD)
  Study design                                                               Definition of KOA used
  Duration of follow-up\*                                                    Definition of BF used
  Number of participants                                                     Definition of RF used†
  Gender (% female)                                                          Number of participants developing KOA\* or with KOA‡
  **Cohort studies**                                                         **Case--control or cross-sectional studies**
  Number of participants developing KOA---exposed to BF/RF                   Number of participants with KOA---exposed to BF/RF
  Number of participants *not* developing KOA---exposed to BF/RF             Number of controls---exposed to BF/RF
  Number of participants developing KOA---*not* exposed to BF/RF             Number of participants with KOA---*not* exposed to BF/RF
  Number of participants *not* developing KOA---*not* exposed to BF/RF       Number of controls---*not* exposed to BF/RF
  *or*                                                                       
  Mean±SD of biomechanical factor within participants developing KOA         Mean±SD of biomechanical factor within participants with KOA
  Mean±SD of biomechanical factor within participants *not* developing KOA   Mean±SD of biomechanical factor within controls
  *or*                                                                       
  ORs for the association between BF/RF and the development of KOA           ORs for the association between BF/RF and KOA

Preferably the numbers of participants are extracted. If these are not available, mean values for the biomechanical or risk factor, or ORs are extracted, respectively.

\*For cohort studies.

†If eligible.

‡For case--control and cross-sectional studies.

BF, biomechanical factor; KOA, knee osteoarthritis; RF, risk factor.

Risk of bias in individual studies {#s2l}
----------------------------------

Risk of bias for each included study will be scored independently by two reviewers (JT and ADI). Consensus on conflicting scores will be reached by discussion. The Quality In Prognostic Studies tool will be used.[@R20] Six areas of potential study biases will be assessed: study participation, study attrition, prognostic factor measurement, study confounding, outcome measurement and statistical analysis and reporting. Risk of bias for study participation is the likelihood that the relationship between the prognostic factor and the outcome is different for participants and eligible non-participants. Risk of bias for study attrition is the likelihood that the relationship between the prognostic factor and the outcome is different for completing and non-completing participants. Risk of bias for prognostic factor measurement is related to differential measurement of the prognostic factor related to the level of outcome. Risk of bias for study confounding is the effect of the prognostic factor being distorted by another factor that is related to the prognostic factor and outcome. Risk of bias for outcome measurement is related to differential measurement of outcome related to the baseline level of the prognostic factor. Risk of bias for statistical analysis and reporting is the risk of bias whether the statistical analysis is dependent on KOA status and the exposure to the biomechanical factor or not, and whether the presentation of results differs between KOA status and exposure. Study attrition is not applicable for cross-sectional and case--control studies, thus will only be rated in cohort studies. Studies will be classified as being of high quality if all study biases are assessed to have a low or moderate risk of bias. Studies with a high risk of bias for at least one study bias will be defined as low-quality studies. A summary statement regarding the quality of the included studies will be reported in the results section.

Assessment of publication bias {#s2m}
------------------------------

It is assumed that biomechanical projects indicating no association between a biomechanical factor and (the development of) KOA are likely to not be published. Therefore, funnel plots will be used to show the OR on the x-axis against the sample size on the y-axis for each biomechanical factor.

Data synthesis {#s2n}
--------------

Data will be grouped by the category abnormal loading and the main biomechanical impairments. Subsequently, data will be grouped per subdivision of biomechanical impairments as shown in [table 1](#BMJOPEN2016011066TB1){ref-type="table"}, and per study design (ie, cohort studies vs a combination of cross-sectional and case--control studies). Biomechanical factors studied in more than one study per study design will be subjected to meta-analyses. Meta-analyses will be applied on the OR of developing KOA in participants who are exposed to the biomechanical factor of interest (cohort studies), or the OR of the biomechanical factor being present in participants with KOA compared to the control group (cross-sectional or case--control studies). Random effects model (Mantel Haenszel method) will be used, as large clinical heterogeneity is expected due to the variation in the definition of KOA and biomechanical factors. Metaregression analyses using study-level risk factors as covariates in a multivariate regression analysis can be used to explore the impact of different biomechanical factors.[@R21] The impact of the biomechanical factors will be assessed by fitting multiple restricted maximum likelihood-based metaregression models.[@R22] [@R23] A priori, we defined a relevant covariate (biomechanical or other risk factor) as one that would decrease the between-study variance (estimated as tau-squared (τ^2^), as a consequence of the inclusion in the meta-regression analysis.[@R24] Meta-regression analysis will also be used to assess the impact of other risk factors, combinations of other risk factors, including interactions between risk factors, on the association of biomechanical factors with (the development of) KOA. A forest plot will be made for each biomechanical factor, and for combinations of biomechanical factors and other risk factors.

Heterogeneity between studies combined in one meta-analysis will be examined with standard Q-tests, and will be calculated as the I^2^ statistics, measuring the proportion of inconsistency in the summary effect measure due to between-study heterogeneity.[@R25] [@R26]

If any substantial heterogeneity will be identified through analysis of χ^2^ and I^2^ statistics, subgroup and sensitivity analyses will be performed. These will only be performed if at least three studies are included in the meta-analysis. Subgroup analyses will be used to explore possible sources of heterogeneity. Subgroups will be based on the outcome definition used, that is, clinical, radiological, MRI and surgical criteria. Subgroups will also be identified based on the ways to measure the biomechanical factor and the duration of follow-up (cohort studies). Other subgroups will be tibiofemoral osteoarthritis and general KOA, and medial and lateral tibiofemoral osteoarthritis. Sensitivity analyses will be carried out based on risk of bias. If sensitivity analyses appear to influence the findings of the review, this will be reported and discussed in the 'Discussion' section.

Confidence in cumulative estimate {#s2o}
---------------------------------

The quality of evidence will be evaluated for the association of the category abnormal loading, and each subdivision of a biomechanical impairment with the (development of) KOA, because this relates to different assessment strategies for clinicians and healthcare providers. The Grading of Recommendation, Assessment, Development and Evaluation framework adapted for prognostic studies will be used.[@R27] Factors that may decrease the quality level of evidence are phase of investigation, study limitations, inconsistency, indirectness, imprecision and publication bias. Factors that may increase the quality level of evidence are moderate or large effect size and exposure-response gradient. It is proposed to base the starting point for the quality level of evidence on phase of investigation. This is not applicable for cross-sectional and case--control studies. Therefore, the starting point for these studies will be low. Quality level of evidence will be determined as high, moderate, low or very low, and will be reported in the summary of findings table. Quality of evidence will also be assessed for combinations of biomechanical factors and risk factors that will be examined in meta-analyses.

An algorithm will be developed that can be used by healthcare providers to identify the biomechanical risk factors which are present in persons at high risk of developing KOA.[@R28] Biomechanical factors will be divided into categories base on study type (longitudinal and cross-sectional/case--control studies) and base of evidence. Evidence will be based on a significant meta-analysis, a longitudinal or cross-sectional/case--control study with a significant finding, an insignificant meta-analysis, or on a longitudinal or cross-sectional/case--control study with insignificant findings. This results in different categories within the algorithm; must consider (significant meta-analysis), maybe consider (study with significant finding), do not consider (insignificant meta-analysis), and not currently clinically relevant (study with insignificant findings).

Ethics and dissemination {#s3}
========================

This article describes the framework for a systematic review and meta-analysis into the association of biomechanical factors with the development of KOA. To the best of our knowledge, performing this will result in the first review that gives an overview of the existing evidence of biomechanical factors that are associated with the development of KOA. This systematic review and meta-analysis protocol does not require ethical approval. The results of this systematic review and meta-analysis will be disseminated via publications in peer-reviewed journals, presentations at (inter)national conferences and patient information.
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